Table 3 Nuclear maturation of rat oocytes in control, sham, and PCOS groups in the absence and presence of metformin
Groups | Without metformin | With metformin | Â | ||||||
|---|---|---|---|---|---|---|---|---|---|
Control | Sham | PCOS | Total | Control | Sham | PCOS | Total | Total | |
N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
GV | 4 (13.79) | 3 (10.34) | 4 (14.28) | 11 (12.79) | 3 (10.34) | 4 (13.79) | 3 (10.71) | 10 (11.62) | 21 (12.20) |
GVBD | 6 (20.68) | 5 (17.24) | 5 (17.85) | 16 (18.60) | 6 (20.68) | 6 (20.68) | 6 (21.42)a | 18 (20.93) | 34 (19.76) |
MI | 6 (20.68) | 6 (20.68) | 5 (17.85) | 17 (19.76) | 7 (24.13) | 7 (24.13) | 6 (21.42) a | 20 (23.25) | 37 (21.51) |
A-T | 1 (3.44) | 3 (10.34) | 2 (7.14) | 6 (6.97) | 1 (3.44) | 1 (3.44) | 2 (7.14) | 4 (4.65) | 10 (5.81) |
MII | 5 (17.24) | 5 (17.24) | 4 (14.28) | 14 (16.27) | 5 (17.24) | 5 (17.24) | 4 (14.28) | 14 (16.27) | 28 (16.27) |
Deg | 2 (6.89) | 2 (6.89) | 3 (10.71) | 7 (8.13) | 2 (6.89) | 1 (3.44) | 3 (10.71) | 6 (6.97) | 13 (7.55) |
ND | 5 (17.24) | 5 (17.24) | 5 (17.85 | 15 (17.44) | 5 (17.24) | 5 (17.24) | 4 (14.28) | 14 (16.27) | 29 (16.86) |
Total | 29 | 29 | 28 | 86 | 29 | 29 | 28 | 86 | 172 |